15 April 2021COMPASS Pathways (CMPS.Q) has study on their COMP360 published in…Piers Eaton CMPS.Q A study was published today in the New England Journal of Medicine which tested COMPASS Pathways’ (CMPS.Q) COMP360 psilocybin. The study is a phase II double-blind, randomized, controlled trial…